Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
Titel:
Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial
Auteur:
Négrier, Sylvie Gravis, Gwenaëlle Pérol, David Chevreau, Christine Delva, Rémy Bay, Jacques-Olivier Blanc, Ellen Ferlay, Céline Geoffrois, Lionnel Rolland, Frédéric Legouffe, Eric Sevin, Emmanuel Laguerre, Brigitte Escudier, Bernard